2020-CA-0660 Precedential Affirmed Ledet, J., Dissents With Reasons Processed

Robert J. Caluda, Aplc and New Orleans Private Patrol Service, Inc. v. the City of New Orleans, Linebarger Goggan, Blair & Sampson, L.L.P. and United Government Services of Louisiana, Inc.

Louisiana Court of Appeal, Fourth Circuit · Filed April 28, 2021

Authorities cited

Identified automatically; this list may not be exhaustive.

Opinion text

ROBERT J. CALUDA, APLC * NO. 2020-CA-0660
AND NEW ORLEANS
PRIVATE PATROL SERVICE, * COURT OF APPEAL
INC.
* FOURTH CIRCUIT
VERSUS
* STATE OF LOUISIANA
THE CITY OF NEW
ORLEANS, LINEBARGER *
GOGGAN, BLAIR &
SAMPSON, L.L.P. AND *
UNITED GOVERNMENT *******
SERVICES OF LOUISIANA,
INC.

LEDET, J., DISSENTS WITH REASONS
RML
LL The narrow issue in this case is whether, as the City contends, the trial court

erred in granting the motion to certify the class, given that the plaintiffs’ class-wide

claims have prescribed.1 Contrary to the majority, I would answer that question in

the affirmative.

Resolution of the issue presented turns on the construction of the special

prescription provision for class actions codified in La. C.C.P. art. 596 (“Article

596”). To provide the necessary background for addressing the issue, it is helpful

to outline the manner in which an earlier-filed class action suit, by applying

prescription suspension principles, can render a later-filed suit timely. See Ansardi

v. Louisiana Citizens Prop. Ins. Corp., 11-1717, p. 23 (La. App. 4 Cir. 3/1/13), 111

So.3d 460, 473. This background, as we observed in Ansardi, has two parts: first,

“the historical and traditional approach to the matter and the rule that emerged”;

and second, “the legislative modification of that rule applicable to class-action

1
In its written reasons for judgment, the trial court explained that the City raised the issue of
prescription both in its peremptory exception of prescription and in its opposition to the motion
to certify. The trial court further explained that it rejected the City’s position that the plaintiff-
class’ claims were prescribed in both contexts. Shortly before the hearing on the motion to
certify, the trial court denied the City’s prescription exception. In certifying the class, the trial
court rejected the City’s argument that the numerosity requirement could not be met given the
plaintiffs’ class-wide claims were prescribed. The City’s appeal is from the trial court’s final
judgment granting the plaintiffs’ motion to certify. The dispositive issue, however, is
prescription.
1

lawsuits pending in Louisiana courts.” Id. As to the first part, we observed in

Ansardi the following:

In American Pipe & Const. Co. v. Utah, 414 U.S. 538, 554, 94
S.Ct. 756, 38 L.Ed.2d 713 (1974), the United States Supreme Court
held that the filing of a class-action suit “suspends the applicable
statute oIf limitations as to all asserted members of the class who
would have been parties had the suit been permitted to continue as a
class action.” Thus, the Court made clear that statutes of limitations,
or prescription statutes, could be tolled by timely filed class-action
lawsuits.

Later, the Louisiana Supreme Court ruled that “since the class
action is brought on behalf of all members of the class, its filing
interrupts prescription as to the claims of all members of the class,
whether they are noticed before or after the prescriptive delay has
terminated.” Williams v. State, 350 So.2d 131, 137 (La.1977). Thus,
the Supreme Court decided that a timely filed class-action lawsuit,
like any other lawsuit under La. Civil Code art. 3462, interrupted the
prescriptive period.

11-1717, pp. 23-24, 111 So.3d at 473.

As to the second part, the Louisiana Legislature, in 1997, modified the

general rule that the filing of a class-action suit interrupted the prescriptive period

by enacting Article 596—“a special provision that prevents prescription from

accruing against the claims of members of a putative class action until the

propriety of the class action or the member's participation in the action is

determined.” Ansardi, 11-1717, p. 24, 111 So.3d at 473 (internal quotations and

citations omitted). Article 596 provides, in pertinent part, as follow:

A. Liberative prescription on the claims arising out of the transactions
or occurrences described in a petition brought on behalf of a class is
suspended on the filing of the petition as to all members of the class as
defined or described therein. Prescription which has been suspended
as provided herein, begins to run again: . . .

(2) As to any person excluded from the class pursuant to Article 592,
thirty days after mailing or other delivery or publication of a notice to
such person that the class has been restricted or otherwise redefined so
as to exclude him . . . .

La. C.C.P. art. 596(A)(2).

2

As we further observed in Ansardi, “[w]ithin the realm of class-action lawsuits,

Article 596 provides a different tolling rule from the rule announced in Williams,

which had been applicable to any class-action lawsuit. Article 596 provides that a

class-action lawsuit pending in a Louisiana court no longer interrupts the

prescriptive period, but suspends the prescriptive period.” Ansardi, 11-1717, p. 24,

111 So.3d at 474. “Thus, to the extent that an individual plaintiff relies upon a

class-action lawsuit pending in a Louisiana court, a district court is to decide

whether the individual lawsuit is timely by applying the specific suspension rules

set out in Article 596.” Ansardi, 11-1717, p. 25, 111 So.3d at 474.

Although Article 596 expressly provides for suspension of prescription when

a former class member seeks to commence an individual lawsuit, such is not the

case here. Indeed, the City concedes that Article 596(A)(2) allows the two named

Caluda plaintiffs, who were excluded from the earlier-filed class action suit, to file

an individual suit. This case is a successive class action suit; the plaintiffs are

seeking to bring class-wide claims. The narrow issue presented, thus, is whether an

earlier-filed class action suit, by applying suspension of prescription principles, can

render a later-filed successor class action suit timely. Simply put, the issue is

whether Article 596 applies to a successor Louisiana class action. This is a res

nova issue.

The City’s argument is that the “named plaintiffs cannot ride on the prior

restricted class action as the vehicle to file a new class action on behalf of a class

of businesses who made payments almost 20 years ago—exposing the City’s fisc

forever.” The majority rejects the City’s argument, reasoning that the City’s

argument is based on principles previously rejected in Duckworth v. Louisiana

Farm Bureau Mut. Ins. Co., 11-2835 (La. 11/2/12), 125 So.3d 1057, and

improperly relies on federal jurisprudence. I respectfully disagree.

3

Following the instructions in Duckworth, I begin my analysis by looking to

the language of the governing statutory provision. Duckworth, 11-2835, p. 13, 125

So.3d at 1064 (observing that “[c]onsistent with the dictates of the civil law, this

court must first look to the language of this codal provision in resolving the issue

presented here—not the jurisprudence and not the decisions of the federal courts”).

The governing statutory provision is Article 596. “Article 596A has two

complementary facets, one involving the suspension of prescription, and the other

its recommencement.” Catherine Palo, 22 LA. CIV. L. TREATISE, SUMMARY

JUDGMENT & RELATED TERMINATION MOTIONS § 2:168 (2021). Here, only the first

part is relevant. Again, the issue presented is whether the suspension of

prescription extends to class-wide claims or successor class actions;

recommencement is not at issue.

By its terms, Article 596 suspends prescription as to “all members of the

class.” Article 596, however, contains no provision suspending prescription to

either class-wide claims or successor class actions. Based on the statutory

language, I would find the City’s prescription exception to the plaintiffs’ class-

wide claims has merit. Moreover, interpreting Article 596 as not extending to

successor class action or class-wide claims is consistent with the United States

Supreme Court’s jurisprudence. In China Agritech, Inc. v. Resh, ___ U.S. ___, ___,

138 S.Ct. 1800, 1804, 201 L.Ed.2d 123 (2018), the Supreme Court observed:

The question presented in the case now before us: Upon denial
of class certification, may a putative class member, in lieu of promptly
joining an existing suit or promptly filing an individual action,
commence a class action anew beyond the time allowed by the
applicable statute of limitations? Our answer is no. American Pipe
tolls the statute of limitations during the pendency of a putative class
action, allowing unnamed class members to join the action
individually or file individual claims if the class fails. But American
Pipe does not permit the maintenance of a follow-on class action past
expiration of the statute of limitations.

In so holding, Justice Ginsberg, writing for the majority, observed:

4

Respondents' proposed reading would allow the statute of
limitations to be extended time and again; as each class is denied
certification, a new named plaintiff could file a class complaint that
resuscitates the litigation. This prospect points up a further distinction
between the individual-claim tolling established by American Pipe
and tolling for successive class actions. The time to file individual
actions once a class action ends is finite, extended only by the time the
class suit was pending; the time for filing successive class suits, if
tolling were allowed, could be limitless. . . . Most statutory schemes
provide for a single limitation period without any outer limit to
safeguard against serial relitigation. Endless tolling of a statute of
limitations is not a result envisioned by American Pipe.

China Agritech, ___ U.S. at ___138 S.Ct. at 1808-09 (internal citations and

footnotes omitted).

As a commentator has observed, the Supreme Court in China Agritech

observed that its holding “would be unlikely to lead to the chaotic filing of

excessive numbers of protective class actions because . . . many Circuits have long

embraced the non-piggyback rule without engendering that consequence.”

William B. Rubenstein, 3 NEWBERG ON CLASS ACTIONS § 9:64 (5th ed. 2020).2

The reasoning set forth in the China Agritech case is equally applicable to

Article 596. Nothing about Louisiana’s unique procedural provisions in our class

action statutory scheme dictates a contrary result. Cf. Quinn v. Louisiana Citizens

Prop. Ins. Corp., 12-0152, p. 11 (La. 11/2/12), 118 So.3d 1011, 1018 (rejecting

cross-jurisdictional tolling and observing that “a closer reading of [Article 596]

reveals its operative provisions are specifically tied to several unique features of

Louisiana class action procedure”).

Lastly, I note that the situation created by the majority’s reading of

Article 596—extending Article 596’s suspension of prescription to successive class

action cases and class-wide claims—is exactly what Justice Weimer warned

against in his dissent in Smith v. Transp. Servs. Co. of Illinois, 13-2788, p. 1 (La.

2
See Smith v. Cutter Biological, 99-2068, pp. 32 (La. App. 4 Cir. 9/6/00), 770 So.2d 392, 410
(observing that “the multiplicity of class action filings relied on by the plaintiffs results in just
such a ‘stacking of class actions’ as was criticized and rejected by Basch v. Ground Round, Inc.,
139 F.3d 6 (1st Cir. 1998)”).
5

7/1/14), 148 So.3d 903, 910 (Weimer, J., dissenting) (observing that “the

suspension effected by La. C.C.P. art. 596 could continue indefinitely—a result at

odds with the very aim and purpose of prescription”). Accordingly, I would reverse

the trial court’s judgment granting the plaintiff’s motion to certify given that the

class-wide claims asserted are prescribed. For these reasons, I respectfully dissent.

6